Analysts: Tenet Healthcare Corp (THC.N)
THC.N on New York Stock Exchange
43.81USD
11:51am EDT
43.81USD
11:51am EDT
Price Change (% chg)
$-0.58 (-1.31%)
$-0.58 (-1.31%)
Prev Close
$44.39
$44.39
Open
$44.15
$44.15
Day's High
$44.22
$44.22
Day's Low
$43.59
$43.59
Volume
49,382
49,382
Avg. Vol
338,290
338,290
52-wk High
$49.47
$49.47
52-wk Low
$17.80
$17.80
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.68 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 8 | 8 | 7 | 7 |
| (2) OUTPERFORM | 4 | 4 | 5 | 5 |
| (3) HOLD | 7 | 6 | 9 | 9 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.95 | 1.89 | 2.10 | 2.10 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 14 | 2,420.59 | 2,600.89 | 2,251.90 | 2,373.85 |
| Quarter Ending Dec-13 | 14 | 2,520.88 | 2,699.56 | 2,322.00 | 2,454.98 |
| Year Ending Dec-13 | 16 | 9,779.61 | 10,522.80 | 9,275.10 | 9,714.35 |
| Year Ending Dec-14 | 15 | 10,386.10 | 11,273.70 | 9,856.00 | 10,464.20 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 19 | 0.68 | 0.77 | 0.51 | 0.52 |
| Quarter Ending Dec-13 | 19 | 1.04 | 1.21 | 0.70 | 1.02 |
| Year Ending Dec-13 | 17 | 2.77 | 2.91 | 2.57 | 2.53 |
| Year Ending Dec-14 | 18 | 3.62 | 4.36 | 2.69 | 2.89 |
| LT Growth Rate (%) | 3 | 8.67 | 10.00 | 6.00 | 11.00 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 2,438.13 | 2,387.00 | 51.13 | 2.10 |
| Quarter Ending Dec-12 | 2,343.57 | 2,331.00 | 12.57 | 0.54 |
| Quarter Ending Sep-12 | 2,240.87 | 2,221.00 | 19.87 | 0.89 |
| Quarter Ending Jun-12 | 2,273.84 | 2,265.00 | 8.84 | 0.39 |
| Quarter Ending Mar-12 | 2,485.47 | 2,350.00 | 135.47 | 5.45 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | 0.30 | 0.33 | 0.03 | 8.98 |
| Quarter Ending Dec-12 | 0.68 | 0.55 | 0.13 | 19.63 |
| Quarter Ending Sep-12 | 0.33 | 0.28 | 0.05 | 16.09 |
| Quarter Ending Jun-12 | 0.07 | 0.40 | 0.33 | 455.56 |
| Quarter Ending Mar-12 | 0.36 | 0.52 | 0.16 | 44.44 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 2,420.59 | 2,420.59 | 2,438.21 | 2,425.31 | 2,373.85 |
| Quarter Ending Dec-13 | 2,520.88 | 2,520.88 | 2,537.19 | 2,517.95 | 2,454.98 |
| Year Ending Dec-13 | 9,779.61 | 9,779.61 | 9,845.51 | 9,823.56 | 9,714.35 |
| Year Ending Dec-14 | 10,386.10 | 10,386.10 | 10,442.70 | 10,370.90 | 10,464.20 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 0.68 | 0.68 | 0.68 | 0.68 | 0.52 |
| Quarter Ending Dec-13 | 1.04 | 1.04 | 1.04 | 1.01 | 1.02 |
| Quarter Ending Dec-13 | 2.77 | 2.77 | 2.80 | 2.84 | 2.53 |
| Quarter Ending Dec-14 | 3.62 | 3.61 | 3.63 | 3.56 | 2.89 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 2 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 1 |
| Year Ending Dec-13 | 0 | 0 | 0 | 4 |
| Year Ending Dec-14 | 0 | 0 | 0 | 4 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 2 | 2 |
| Quarter Ending Dec-13 | 0 | 0 | 2 | 2 |
| Year Ending Dec-13 | 0 | 0 | 1 | 3 |
| Year Ending Dec-14 | 0 | 0 | 1 | 3 |
- Hospital chain Tenet to buy Vanguard Health for $1.73 billion
|
- UPDATE 4-Hospital chain Tenet to buy Vanguard Health for $1.73 bln
- Tenet acquisition of Vanguard puts M&A deal in pipeline
- Tenet Healthcare to buy Vanguard Health for $4.3 bln
- ANALYSIS-Hospital investors sold on U.S. health reform despite bumps
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Trading Report for (THC). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: MacroRisk Analytics/EconomicInvestor
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates